Toggle navigation
Home
Search
Services
Blog
Contact
About
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F.
Baker Norton Pharmaceuticals, Inc., Miami, FL, United States
Search 7 grants from Elliot Hahn
Search grants from Baker Norton Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Informatics platform for mammalian gene regulation at isoform-level
IInfection-Elicited Oral Bone Loss: TLR2, Ontogency, and Porphromonas Gingivalis
Effectiveness of Hospital-Based Program for Vaccination of Birth Mothers and Hous
Pheromone Signals Transduction in Vomeronasal Neurons
Immunobiology of the Scurfy Mouse
Recently added grants:
Northwestern University Lead Academic Participating Site
UM LAPs - UG1 Grant
UG1 - NCTN (Network Lead)
Identifying the pro-metastatic mechanisms of neutrophil extracellular traps
Tissue-Engineered Models of Microvessel-Mediated Glioblastoma Invasion
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI028124-03
Application #
2064264
Study Section
Physiological Sciences Study Section (PSF)
Project Start
1989-06-01
Project End
1992-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Baker Norton Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33178
Related projects
NIH 1991
R44 AI
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F. / Baker Norton Pharmaceuticals, Inc.
NIH 1990
R44 AI
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F. / Baker Norton Pharmaceuticals, Inc.
Comments
Be the first to comment on Elliot Hahn's grant